Pituitary adenoma: the common, usually-benign brain-gland tumor
Last updated September 3, 2026.
A pituitary adenoma is the benign tumor of the pituitary gland (the master hormone gland at the brain's base): the common kind (the up-to-1-in-10 people harbor one, mostly never knowing), and the usually-benign row throughout: the problems come from the two mechanisms: the hormone over-production (the prolactin, the growth-hormone, the cortisol kinds) or the size pressing (the vision, the headaches, the hormone-underproduction). The treatment ranges from the watching (the small incidental kind) to the tablets (the prolactinomas: the shrink-on-medication kind) to the surgery (the through-the-nose kind: the effective and the kind-to-the-brain).
What does it cause?
The hormone-overproduction kinds: the prolactinoma (the commonest: the milk-discharge, the periods-stopping, the libido-erectile rows in the men), the growth-hormone kind (the acromegaly: the hands-feet-jaw enlarging), the cortisol kind (the Cushing's: the weight-face-bruising rows). The pressing-kind (the macroadenomas): the vision loss (the outer-fields first: the bumping-into-things kind), the headaches, and the under-production (the fatigue, the low-libido, the thyroid-cortisol rows). The incidental-kind: the found-on-the-scan-for-something-else, the commonest modern row.
Why does it happen?
The sporadic in the most (the no-known-cause row: not the stress, not the lifestyle), with the small hereditary fraction (the MEN1-kind). The benign throughout (the pituitary-cancer is the extreme-rarity), and the behavior matters more than the word tumor: the what-it-makes and the how-big questions drive everything.
How is it treated?
- The watching: the small non-functioning kind (the no-hormone, the no-pressing): the scan-surveillance only (the many never need the more).
- The tablets for the prolactinoma: the cabergoline-kind (the dopamine-agonists: the tumor shrinking and the hormone normalizing in the great majority: the medical cure-the-effect kind).
- The surgery for the others: the transsphenoidal kind (the through-the-nose: the no-skin-cut row: the vision often improving within the days), for the pressing-kind, the acromegaly-Cushing kinds, and the tablet-failures.
- The hormones replaced when needed: the under-production kinds get the replacements (the thyroid, the cortisol, the sex-hormones: the cortisol-replacement is the never-miss kind: the sickness-rules taught).
- The radiotherapy for the remnants: the selected recurring-kind rows.
When is it urgent?
The same-day-or-ER for: the sudden severe headache with the vision loss (the pituitary apoplexy: the bleed-into-the-tumor: the emergency), the rapid vision loss, and the vomiting-with-confusion on the cortisol-replacement (the adrenal-crisis row). Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
Is a pituitary adenoma brain cancer?
No: the adenoma is the benign tumor (the non-spreading kind: the growing-locally-at-most row), and the pituitary-cancer is the extreme-rarity (the vanishing-kind: not what the word adenoma means). The word tumor is doing the terror: the biology here is the benign kind, and the management-question is never the is-it-cancer row: it is the is-it-making-hormones and the is-it-big-enough-to-press rows.
How common are these, really?
The surprising row: the imaging-and-autopsy studies find the small pituitary adenomas in the around-1-in-10 of the general population (the mostly-tiny, the never-symptomatic kind), and the MRI era finds them constantly on the scans-for-other-reasons (the headaches, the sinus rows: your row). The vast majority of the incidental kind need the hormone-check-plus-watching only, and the many need nothing further ever.
What will the endocrinology appointment involve?
The two-questions visit: the history (the periods, the libido, the milk-discharge, the growth-changes, the fatigue: the hormone-symptom hunt) and the blood tests (the prolactin, the growth-hormone-row, the cortisol, the thyroid, the sex-hormones: the full panel), with the visual-fields testing if the size warrants (the 7-mm kind is below the pressing-threshold usually), and the outcome-mapping (the all-normal-plus-small row lands the surveillance: the scan-in-a-year kind).
Will I need brain surgery?
The probably-not for your kind: the surgery (the transsphenoidal: the through-the-nose row, the no-visible-scar kind) is reserved for the pressing-kind (the vision threatened), the hormone-overproducing kinds the tablets cannot fix (the acromegaly-Cushing rows), and the growing-on-surveillance kind. The 7-mm non-symptomatic row is the watching-kind in the overwhelming majority: the many never meet the surgeon at all.
Could it grow? What then?
The some grow (the slow-kind usually), which is the entire point of the surveillance (the periodic scans: the growth caught the years-early), and the growing-kind then gets the treatment at the right moment (the surgery for the pressing-kind, the tablets for the prolactin-kind: the shrinkage achievable), so the watching is not the neglect: it is the early-catching machine. The stable-after-the-first-few-scans kind often spaces out further.
What symptoms should make me call before the appointment?
The short actionable list: the vision changes (the bumping-into-things, the outer-vision-missing kind: the fields testing the formal row), the headaches clearly worsening (the especially the new-severe kind), and the emergency-kind: the sudden-thunderclap headache with the vision loss (the pituitary apoplexy: the bleed-into-the-tumor: the rare, the same-day-ER kind). The hormone-symptom drift (the periods stopping, the milk-discharge, the libido changes) is the mention-at-the-appointment row, and the note-taking between-now-and-then helps the visit.